Houston Methodist Hospital
M

Transplant Oncology: An Evolving Field in Cancer Treatment

By Houston Methodist Hospital FEATURING Maen Abdelrahim
By Houston Methodist Hospital FEATURING Maen Abdelrahim
21 views
September 29, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Related Content

AUTOPLAY
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
15:51
Total Health

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Feat. A. Grothey
13:29
Ibrahim Sahin

Treating KRAS-Mutated mCRC

26:59
University of Texas Southwestern Medical Center

2023 AASLD Guidance for HCC

Feat. A. Singal
18:02
Ibrahim Sahin

Treating HER2-Amplified mCRC

11:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Bas…

Feat. S. Stintzing
15:56
Van Morris

ASCO Updated Guidelines for the Treatment of Metastatic Colorectal C…

Feat. C. Eng
07:16
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "CheckMate-8HW Clinical Implica…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
16:39
UChicago Medicine

Treatment of mCRC After Standard Chemotherapy

Feat. A. Shergill
06:26
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "64-Month Follow-Up From CheckMate 142 - 1…

Feat. H. Lenz
18:23
Ibrahim Sahin

Treating BRAF-Mutated mCRC

12:04
Arndt Vogel

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

14:54
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa
25:57
Northwestern Medicine Oncology and Hematology

ASCO®, ESMO, and NCCN Guidelines on Treatment and Biomarker Testing/…

Feat. A. Benson
18:34
Total Health

Management of Colorectal Liver Metastases

Feat. S. Gholami
21:24
Fred Hutchinson Cancer Center

Re-Challenge With Systemic Therapy for mCRC

Feat. R. Hsieh
06:05
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results From the GALAXY Study in …

Feat. E. Oki
25:12
2023 Evolution Conference

IO and Targeted Therapy in mCRC

Feat. L. Connell
13:17
Heinz-Josef Lenz

Update on Targeted Agents in Colorectal Cancer

08:41
ASCO 2022 Conference Coverage

ASCO 2022 on KEYNOTE-651: Pembrolizumab + mFOLFOX7/FOLFIRI for mCRC:…

Feat. R. Kim